what is ozurdex approved for?
OZURDEX® (dexamethasone intravitreal implant) is indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). OZURDEX® is indicated for the treatment of non-infectious uveitis affecting the posterior segment of the eye.